$CLS

CELESTICA INC (CLS): Entry into a Material Definitive Agreement

CELESTICA INC (CLS) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-1.1 2 tm2621135d2_ex1-1.htm EXHIBIT 1.1 Exhibit 1.1 EXECUTION VERSION Celestica Inc. Common Shares Underwriting Agreement August 5, 2026 Citigroup Global Markets Inc. 388 Greenwich Street New York, New York 10013 BofA Securities, Inc. One Bryant Park New York, New York 10036 T

Original reporting
Published Aug 7, 2026, 8:01 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 7, 2026, 8:07 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$CLS
Neutral
medium confidence
Mentioned
$CLS
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$CLSNeutralMed
01

Why it matters

This is a capital markets event. The key tradable variable is the equity issuance overhang (firm shares plus potential additional shares), which can affect valuation and liquidity expectations.

02

Market read

A new equity offering structure is disclosed, creating potential near-term dilution risk and a catalyst for repricing until pricing and proceeds details are known.

03

What to watch

Traders will want the missing terms: offering price, expected closing date, use of proceeds, and whether the underwriters’ option is likely to be exercised.

Relevance 6/10Novelty 7/10Timing: filed Aug 7, 2026 (after close)

Background

The 8-K Item 1.01 reports entry into a material definitive agreement, with an exhibit describing an underwriting agreement tied to a shelf registration.

Company-level read

Ticker impact

$CLSNeutralMedium confidence
Context

Celestica entered a material definitive underwriting agreement to issue 9,677,419 common shares plus an option for 1,451,612 more.

Expected impact

Near-term downside bias is possible on dilution concerns, with direction depending on offering size versus demand and any disclosed pricing terms (not included in the excerpt).

Evidence & confidence

The filing is a primary-source disclosure of a capital raise structure (firm shares plus over-allotment option). The excerpt does not include offer price, proceeds, or use of funds, limiting precision on magnitude and timing.

Market effects

Adds to the broader signal that industrial/tech supply-chain firms may be using shelf capacity for equity financing.

Limited, as the disclosure is company-specific and not a macro policy action.

Low; underwriting mechanics are typically localized to the issuer and its investor base.

Counterpoint

If the offering is priced attractively or supports accretive growth, the dilution overhang may be temporary and quickly absorbed by investors.

Key entities

  • Celestica Inc.

    Ontario corporation filing the 8-K and underwriting agreement for a common share issuance.

  • Citigroup Global Markets Inc.

    Named underwriter in the underwriting agreement exhibit.

  • BofA Securities, Inc.

    Named underwriter in the underwriting agreement exhibit.

  • TD Securities Inc.

    Named underwriter in the underwriting agreement exhibit.

Related articles

$CLSMedAI 8/10

Celestica Completes Equity Offering

Celestica Inc. (NYSE: CLS, TSX: CLS) said it completed its equity offering of 9,677,419 common shares at $310 per share. Including the underwriters’ option, 11,129,031 shares were sold for about $3.45 billion in gross proceeds. Net proceeds will be used for working capital, capital expenditures, and general corporate purposes.

$CLSHighAI 9/10

Celestica Falls After Pricing $3 Bln Equity Offering

Celestica Inc. (CLS) shares fell nearly 12% after the company priced a $3.0 billion public equity offering. According to the company, it sold 9.68 million common shares at $310 each, raising expected gross proceeds of $3.0 billion, and gave underwriters a 30-day option for up to 1.45 million additional shares. CLS traded around $319.48, down about $43.28.

$CLSHighAI 9/10

Why is Celestica stock sliding today?

Celestica (CLS) shares fell 13.7% after the company priced a $3 billion common stock offering at $310 per share, down from the prior close of $362.76. Celestica plans to sell about 9.68 million treasury shares, with underwriters able to buy 1.45 million more. Management said the raise supports AI compute and networking demand.

$CLSMedAI 8/10

Celestica Announces Pricing of Equity Offering

Celestica Inc. (NYSE: CLS, TSX: CLS) priced an equity offering of 9,677,419 common shares at $310 per share. Gross proceeds are expected at about $3.0 billion before underwriting discounts and expenses. Underwriters have a 30-day option to buy up to 1,451,612 additional shares. Net proceeds will fund working capital and capital expenditures, among other purposes. Closing is expected around Aug. 7, 2026.